Silvant Capital Management’s Allergan plc AGN Stock Holding History

Silvant Capital Management’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-261	Closed	-$46K	–	351
2020 Q1	$46K	Hold	261	–	–	0.01%	244
2019 Q4	$50K	Hold	261	–	–	0.01%	269
2019 Q3	$44K	Sell	261 -57	-18%	-$9.29K	0.01%	278
2019 Q2	$53K	Hold	318	–	–	0.01%	280
2019 Q1	$47K	Hold	318	–	–	0.01%	282
2018 Q4	$43K	Hold	318	–	–	0.01%	284
2018 Q3	$61K	Hold	318	–	–	0.01%	276
2018 Q2	$53K	Hold	318	–	–	0.01%	281
2018 Q1	$54K	Buy	+318	New	+$53.3K	0.01%	285

Other funds holding AGN

Ashburton (Jersey) St Helier, Jersey $227M AUM

Cerebellum San Francisco, California $21.5M AUM

Barings Charlotte, North Carolina $6.19B AUM 16.5% 1-Year Est. Return

JDC-JSC New York $20.8M AUM 30.94% 1-Year Est. Return

VFA

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

OPS

Orion Portfolio Solutions Omaha, Nebraska $10.2B AUM 6.73% 1-Year Est. Return

Silvant Capital Management's AGN Position: Q2 2020 in Review

Silvant Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 261 shares — an estimated $46K sold.

Silvant Capital Management first reported a position in AGN in Q1 2018 and held it in 9 quarters. The position peaked at $61K in Q3 2018. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

Silvant Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
Silvant Capital Management sold 261 Allergan plc shares in Q2 2020, an estimated $46K.
Silvant Capital Management first reported a position in Allergan plc in Q1 2018 and held it in 9 quarters.
Silvant Capital Management's Allergan plc position peaked at $61K in Q3 2018.
7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Silvant Capital Management's 13F filing for Q2 2020, filed 11 Aug 2020.